161 related articles for article (PubMed ID: 12716234)
21. [Psychiatric clinical picture and psychopharmaca].
Bohle FJ
Mitt Dtsch Pharm Ges Pharm Ges DDR; 1970 Sep; 40(9):225-45. PubMed ID: 4394715
[No Abstract] [Full Text] [Related]
22. Upgrading psychopharmacology in a private psychiatric hospital.
Targum SD; Kessler KA; Waletzky JP; Capodanno AE
Hosp Community Psychiatry; 1984 Apr; 35(4):385-7. PubMed ID: 6714951
[No Abstract] [Full Text] [Related]
23. Challenges and Promises of Pediatric Psychopharmacology.
Giles LL; Martini DR
Acad Pediatr; 2016 Aug; 16(6):508-18. PubMed ID: 27064142
[TBL] [Abstract][Full Text] [Related]
24. [The use of psychopharmaceuticals, psychostimulants and antidepressants in children and adolescents].
Sørensen L
Ugeskr Laeger; 1998 Dec; 160(51):7433-7. PubMed ID: 9889658
[TBL] [Abstract][Full Text] [Related]
25. Psychopharmacology: a house divided.
Dean CE
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):1-10. PubMed ID: 20828593
[TBL] [Abstract][Full Text] [Related]
26. The National Institute of Mental Health-Psychotherapeutic Medications Development Program (PMDP): status 1993.
Haigler HJ
Psychopharmacol Bull; 1994; 30(1):19-22. PubMed ID: 7972624
[No Abstract] [Full Text] [Related]
27. Drugs used in the treatment of childhood psychiatric disorders.
Singhal PK; Bhatia MS; Bohra N; Dutta AK
Indian Pediatr; 1991 May; 28(5):527-39. PubMed ID: 1752681
[No Abstract] [Full Text] [Related]
28. Prescribing of psychotropic medication by primary care physicians and psychiatrists.
Beardsley RS; Gardocki GJ; Larson DB; Hidalgo J
Arch Gen Psychiatry; 1988 Dec; 45(12):1117-9. PubMed ID: 2904248
[TBL] [Abstract][Full Text] [Related]
29. Update on geriatric psychopharmacology.
Salzman C
Geriatrics; 1979 Aug; 34(8):87-90. PubMed ID: 447090
[No Abstract] [Full Text] [Related]
30. What is the blood-brain barrier? I've heard that it may have something to do with psychiatric disorders. Is that true?
Miller MC
Harv Ment Health Lett; 2010 Nov; 27(5):8. PubMed ID: 21218616
[No Abstract] [Full Text] [Related]
31. [Significance of psychopharmacology in psychiatry].
Vinar O
Psychiatr Neurol Med Psychol (Leipz); 1965 Nov; 17(11):411-8. PubMed ID: 4380039
[No Abstract] [Full Text] [Related]
32. [Special characteristics of psychopharmacotherapy of elderly patients].
Bauer J
Fortschr Med; 1996 Sep; 114(25):297-302. PubMed ID: 8974977
[TBL] [Abstract][Full Text] [Related]
33. The nature and extent of psychotropic drug usage in the United States.
Balter MB; Levine J
Psychopharmacol Bull; 1969 Oct; 5(4):3-13. PubMed ID: 4391807
[No Abstract] [Full Text] [Related]
34. [Bioelectric cerebral changes in course of psychiatric treatment].
Seva Díaz A
Arch Neurobiol (Madr); 1974; 37(6):545-60. PubMed ID: 4156641
[No Abstract] [Full Text] [Related]
35. [New psychotropic drugs (review of the literature)].
Kotikov GM; Lerner VE
Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(3):132-43. PubMed ID: 2163155
[No Abstract] [Full Text] [Related]
36. The use and abuses of drugs in psychiatry.
Shepherd M
Lancet; 1970 Jan; 1(7636):31-3. PubMed ID: 4188353
[No Abstract] [Full Text] [Related]
37. Psychopharmacology in cross-cultural psychiatry.
Lin KM
Mt Sinai J Med; 1996; 63(5-6):283-4. PubMed ID: 8898528
[No Abstract] [Full Text] [Related]
38. [Road safety under psychiatric drug targeting].
Brunnauer A; Laux G
Fortschr Neurol Psychiatr; 2008 Jun; 76(6):366-77. PubMed ID: 18512188
[No Abstract] [Full Text] [Related]
39. Looking back to the future of psychopharmacology.
Hirshbein L
J Nerv Ment Dis; 2012 Dec; 200(12):1109-12. PubMed ID: 23183368
[TBL] [Abstract][Full Text] [Related]
40. Period prevalence of concomitant psychotropic medication usage among children and adolescents with attention-deficit/hyperactivity disorder during 2009.
Betts KA; Sikirica V; Hodgkins P; Zhou Z; Xie J; DeLeon A; Erder MH; Wu EQ
J Child Adolesc Psychopharmacol; 2014 Jun; 24(5):260-8. PubMed ID: 24839998
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
